As many as 450 enterprises from 23 countries and territories around the globe have registered to participate in the 23rd ...

Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that ...

Duchenne muscular dystrophy (DMD) has long been one of the most devastating genetic disorders to affect children. Marked by progressive muscle degeneration, early loss of mobility, and eventual ...

Researchers report that rentosertib, an AI-discovered TNIK inhibitor, showed promising safety and potential to improve lung ...

You can help your dad prioritize wellness and recovery with some easy-to-use, high-tech gear. Whether it's a pair of Normatec ...

This review aimed to evaluate the effectiveness of homeopathic treatments for respiratory infections, particularly upper respiratory tract infections (URTIs) like pharyngitis caused by Streptococcus ...

Breath New Life Into Your Business. Tranquil Elegance with 3D Salt Art. True craftsmanship rooted in tradition. Salt cave exp ...

Get ready to experience the best of Taiwan’s award-winning innovations at the Taiwan Excellence Pavilion, taking place from ...

The surge in smoking and vaping among teenagers is a growing concern, with many teenagers considering these habits as trendy ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

At current levels, GRFS scores over ADMA with cheaper valuation, a broad portfolio, and strong EPS growth estimates despite the latter's robust Asceniv-driven momentum.

Inhalable nanovaccines offer needle-free, mucosal immunity against respiratory diseases like COVID-19, influenza, and TB.